ArticleHepatology international2022

Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mL.

Hankil Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.